2Department of Public Health Nursing, Selçuk University, Faculty of Health Sciences, Konya-Turkey
3Department of Hematology-Oncology, Health Sciences University, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara-Turkey DOI : 10.5505/tjo.2019.2010 OBJECTIVE
The present study aimed to test the validity and reliability of the Geriatrics 8 (G8) tool, a risk-screening tool for further comprehensive geriatric assessment, with hematologic cancer patients aged 65 years and older.
METHODS
This methodological study included 110 patients followed up for hematologic cancer. Data were collected
using the patient identification form, the G8 screening tool, and the Edmonton Frail Scale. Language
and content validity, internal consistency, confirmatory factor, sensitivity and specificity and concurrent
validity analyses were also used.
RESULTS
Patients (mean age: 73.9±6.10) were diagnosed with lymphoma (30.9%), multiple myeloma (21.8%),
leukemia (20.9%), myelodysplastic syndrome (19.1%). Confirmatory factor model fit index analysis ?²/
df and p-values (0.14) showed a good fit and GFI, AGFI, SRMR, and RMSEA values showed acceptable
fit. The Cronbach"s alpha coefficient was 0.655, area under the ROC curve was 0.824 (95%, 0.745?0.904),
and sensitivity and specificity were 61.0% and 88.9%, respectively.
CONCLUSION
The findings indicated that the G8 screening tool was found a valid and reliable tool for geriatric patients
diagnosed with cancer to determine the risk and need for further comprehensive geriatric assessment.